TW200801034A - Novel sea lice vaccine - Google Patents
Novel sea lice vaccineInfo
- Publication number
- TW200801034A TW200801034A TW095135847A TW95135847A TW200801034A TW 200801034 A TW200801034 A TW 200801034A TW 095135847 A TW095135847 A TW 095135847A TW 95135847 A TW95135847 A TW 95135847A TW 200801034 A TW200801034 A TW 200801034A
- Authority
- TW
- Taiwan
- Prior art keywords
- protein
- nucleic acid
- acid sequences
- vaccines
- sea lice
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 6
- 241001674048 Phthiraptera Species 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 12
- 102000004169 proteins and genes Human genes 0.000 abstract 12
- 150000007523 nucleic acids Chemical group 0.000 abstract 5
- 108020004414 DNA Proteins 0.000 abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 241000277331 Salmonidae Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Insects & Arthropods (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to 200 kD protein, a 180 kD protein, a 100/85 kD protein and a79 kD protein. The invention further relates too nucleic acid sequences encoding a 200 kD protein, a 180 kD protein, a 100/85 kD protein and a79 kD protein, to vaccines comprising these proteins or nucleic acid sequences encoding the proteins, to DNA fragments, recombinant DNA molecules, live recombinant carriers and to host cells comprising such nucleic acid sequences, to vaccines comprising such DNA fragments, recombinant DNA molecules, live recombinant carriers and to host cells comprising such nucleic acid sequences, to methods for the preparation of such vaccines and to the use of such protein or nucleic acid sequences encoding such protein in vaccines and for the manufacture of a vaccine for combating sea lice infection in salmonids.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05109260 | 2005-10-05 | ||
| EP05109261 | 2005-10-05 | ||
| EP05109259 | 2005-10-05 | ||
| EP05109258 | 2005-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200801034A true TW200801034A (en) | 2008-01-01 |
Family
ID=37696028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095135847A TW200801034A (en) | 2005-10-05 | 2006-09-27 | Novel sea lice vaccine |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1934247A1 (en) |
| JP (1) | JP2009511005A (en) |
| CA (1) | CA2624486A1 (en) |
| DK (2) | DK200800635A (en) |
| NO (1) | NO20081541L (en) |
| TW (1) | TW200801034A (en) |
| WO (1) | WO2007039599A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8207132B2 (en) * | 2004-07-28 | 2012-06-26 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| CU23634A1 (en) | 2007-05-31 | 2011-02-24 | Ct Ingenieria Genetica Biotech | SEQUENCES OF NUCLEIC ACID AND AMINO ACIDS, AND VACCINE FOR THE CONTROL OF INFESTATIONS BY ECTOPARASITES IN FISH |
| WO2009067020A1 (en) | 2007-11-19 | 2009-05-28 | Calanus As | Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites |
| GB201902425D0 (en) * | 2019-02-22 | 2019-04-10 | Benchmark Animal Health Ltd | Sea lice antigens and vaccines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8207132B2 (en) * | 2004-07-28 | 2012-06-26 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
-
2006
- 2006-09-27 TW TW095135847A patent/TW200801034A/en unknown
- 2006-10-03 CA CA002624486A patent/CA2624486A1/en not_active Abandoned
- 2006-10-03 EP EP06806932A patent/EP1934247A1/en not_active Withdrawn
- 2006-10-03 WO PCT/EP2006/066978 patent/WO2007039599A1/en not_active Ceased
- 2006-10-03 JP JP2008533995A patent/JP2009511005A/en active Pending
-
2008
- 2008-03-31 NO NO20081541A patent/NO20081541L/en not_active Application Discontinuation
- 2008-05-05 DK DK200800635A patent/DK200800635A/en not_active Application Discontinuation
-
2010
- 2010-03-05 DK DKPA201070087A patent/DK201070087A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007039599A1 (en) | 2007-04-12 |
| EP1934247A1 (en) | 2008-06-25 |
| DK201070087A (en) | 2010-03-05 |
| DK200800635A (en) | 2008-05-05 |
| NO20081541L (en) | 2008-07-02 |
| CA2624486A1 (en) | 2007-04-12 |
| JP2009511005A (en) | 2009-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201071323A1 (en) | AXMI-115, AXMI-113, AXMI-005, AXMI-163, AXMI-184 INSECTICIDE PROTEINS AND METHODS OF THEIR APPLICATION | |
| NZ591415A (en) | Haemophilus influenzae type B | |
| EA201170980A1 (en) | PESTICIDAL PROTEINS AND METHODS OF THEIR APPLICATION | |
| IL220133A0 (en) | Nucleic acid molecules and recombinant vaccines comprising sequences encoding immunogens and immunomodulators, compositions comprising said nucleic acid molecules, and uses of said nucleic acid molecules, recombinant vaccines, compositions and immunogens and immunomodulators in the preparation of medicaments and as medicaments | |
| RU2016146198A (en) | THERAPEUTIC DLL4-BINDING PROTEINS | |
| MX358725B (en) | Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same. | |
| PH12012502272A1 (en) | Biological materials related to her3 | |
| MX2010005783A (en) | Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same. | |
| TW201129379A (en) | Anti-Orai1 antigen binding proteins and uses thereof | |
| WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
| HRP20130022T1 (en) | Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1 | |
| ATE470673T1 (en) | VACCINES CONTAINING LAWSONIAINTRACELLULAR SUBUNIT | |
| MX2009007261A (en) | Foxp3 peptide vaccine. | |
| KR20090016671A (en) | Replikin peptides and uses thereof | |
| MX381786B (en) | INSECTICIDE GENE VARIANT AXMI115 AND METHODS FOR USING IT. | |
| NO20081541L (en) | New sea lice vaccine | |
| DK1664100T3 (en) | Vaccine with subunit of Lawsonia intracellularis | |
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| ATE450546T1 (en) | VACCINES CONTAINING ORNITHOBACTERIUM RHINOTRACHEALE SUBUNIT | |
| WO2006113782A3 (en) | Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof | |
| AR040830A1 (en) | VACCINE TO COMBAT THE INFECTION THAT PRODUCES THE MASTITIS | |
| AR041243A1 (en) | VACCINE FOR OSTERTAGY | |
| TH88495B (en) | A new vaccine for marine parasites | |
| DE60100879D1 (en) | Helicobacter felis vaccine |